logo

Q301--New €“ Stx Specialized Molecular Residual Disease Testing

Special notice · United States of America

Source: SAM.gov

Tender
Special Notice

Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3 1. NOTICE OF INTENT DESCRIPTION The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole

Status
Prospective
Sector
Residential, Road, Commercial, Hospital
Location
United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Q301--New €“ Stx Specialized Molecular Residual Disease Testing

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Q301--New €“ Stx Specialized Molecular Residual Disease Testing” is a tender record in Taiyo, linked to the Residential sector. It is issued for works, goods, or services related to United States of America.

Participants

Not available for this record.

Status

Original status

special notice

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3 1. NOTICE OF INTENT DESCRIPTION The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease. 2. SUPPLIES/SERVICES Item 0001 Description: Signatera Only, CPT Codes 81479, 81455 Estimated Quantity: 35 Unit: Each Item 0002 Description: Prospera, CPT Code 81479 Estimated Quantity: 25 Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including: Prospera molecular expression transplant assessment test Signatera Residual Disease Test (MRD) (non liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests. 3. SOLE SOURCE JUSTIFICATION Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, third party laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the necessary technology, reagents, and bioinformatics platforms. 4. THIS NOTICE IS NOT A REQUEST FOR QUOTES This Special Notice is issued solely for information and planning purposes. It does not constitute a solicitation or a request for competitive quotes. Interested parties may submit a capability statement demonstrating an ability to perform the required testing. Responses must clearly show that an equivalent proprietary test exists and can be provided. 5. RESPONSE INSTRUCTIONS Responses must be emailed to: Susan Flores Contract Specialist, NCO 17 Email: Susan.Flores2@va.gov Deadline: November 2, 2026 at 10:00 AM CST The Government will review all responses but retains discretion regarding whether to compete this requirement. The Government is not responsible for any costs incurred in responding to this notice. 6. PLACE OF PERFORMANCE VA Facilities within VISN 17 (Texas) Specific ordering locations will be identified in individual task/delivery orders. 7. PERIOD OF PERFORMANCE Five ordering periods (exact dates to be determined at award).

Original sector

Health Care and Social Assistance

Location

Country

United States of America (USA)

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Residential, Road, Commercial, Hospital

Article published date

2026-10-23

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender